ReNeuron Group PLC (RQE.L)

Pharmaceuticals - Generic & Specialty

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Share Price

Share Intraday Performance
-0.2p (-5.41%)
Bid: 3.3p Offer: 3.8p
As of: 26 May 2016 16:13
Market Capitalisation: £110.76 million
Shares In Issue: 3,164.62 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   6.4p on 11-Jun-15
52 week low:   2.5p on 08-Dec-15

Financial History

to Mar '13to Mar '14to Mar '15
Operating Profit-£7m-£8m-£10m
Total Operating Expense£7m£8m£10m
Net Profit-£6m-£7m-£9m
Net Profit Before Taxes-£7m-£8m-£10m
Net Profit After Taxes-£6m-£7m-£9m

Sponsored by:

Company Information
Number of Shares Out 3,164.62m
Number of Shares Floating 3,030.36m
Number of Common Share Holders
Number of Employees 33
Key Figures
Volume (10 day Avg.) 0.95673m
Turnover £0.03m
Profit Before Tax £-8.91m
EPS -0.50p
Cashflow Per Share -0.49p
Cash Per Share 0.69p